Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia

NCT ID: NCT03121586

Last Updated: 2025-08-24

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE3

Total Enrollment

995 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-31

Study Completion Date

2024-05-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the long-term safety and tolerability of pimavanserin after 52 weeks of adjunctive treatment in subjects with schizophrenia

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Schizophrenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Drug - Pimavanserin

Pimavanserin 34 mg, 20 mg, or 10 mg, + background antipsychotic, taken once daily by mouth

Group Type EXPERIMENTAL

Pimavanserin

Intervention Type DRUG

Pimavanserin 10 mg, tablet, taken as one 10 mg tablets, once daily by mouth, OR Pimavanserin 20 mg, tablet, taken as two 10 mg tablets, once daily by mouth, OR Pimavanserin 34 mg, tablet, taken as two 17 mg tablets, once daily by mouth

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pimavanserin

Pimavanserin 10 mg, tablet, taken as one 10 mg tablets, once daily by mouth, OR Pimavanserin 20 mg, tablet, taken as two 10 mg tablets, once daily by mouth, OR Pimavanserin 34 mg, tablet, taken as two 17 mg tablets, once daily by mouth

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patient is able to understand and provide signed informed consent
2. Has a caregiver or some other identified responsible person (e.g., family member, social worker, caseworker, or nurse) considered reliable by the Investigator in providing support to the subject to help ensure compliance with study treatment, study visits, and protocol procedures and who is also able to provide input helpful for completing study rating scale
3. Is completing the Week 6 visit in Study ACP-103-034 or the Week 26 visit in Study ACP-103-038 or 064 while continuing to take his/her assigned dose of blinded study drug and may, in the Investigator's opinion, benefit from continued adjunctive treatment with pimavanserin to a antipsychotic
4. If the subject is female, she must not be pregnant or breastfeeding. She must also be of non-childbearing potential (defined as either surgically sterilized or at least 1 year postmenopausal) or must agree to use two clinically acceptable methods of contraception
5. The main background antipsychotic with which the subject is being treated must continue to be on one of the antipsychotics listed below:

* Aripiprazole
* Aripiprazole long-acting injectables:

* Abilify Maintena®
* Aristada®
* Asenapine
* Risperidone
* Risperidone long-acting injection
* Olanzapine
* Paliperidone extended release (ER) (≤9 mg)
* Paliperidone palmitate

* Invega Sustenna® (≤156 mg)
* Invega Trinza® (≤546 mg)
* Trevicta® (≤350 mg)
* Xeplion® (≤100 mg)
* Lurasidone
* Cariprazine
* Brexpiprazole
* Asenapine

Exclusion Criteria

1. Patient is judged by the Investigator or the Medical Monitor to be inappropriate for the study (e.g., significantly noncompliant in Studies ACP-103-034, -038, or -064)
2. A urine drug screen (UDS) result at Baseline that indicates the presence of any tested prohibited substance of potential abuse

1. Subjects from Studies 034 and 038 with a result indicating the presence of marijuana are permitted, if allowed by medical regulations, if they agree to abstain from marijuana use during the study and the medical monitor approves the subject's participation
2. Subjects from Study 064 with a result indicating the presence of marijuana are not permitted in the study
3. Is taking a medication or drug or other substance that is prohibited according to this protocol
4. Known family or personal history or symptoms of long QT syndrome or risk factors for torsade de pointes and/or sudden death, including symptomatic bradycardia, hypokalemia or hypomagnesemia, and the presence of congenital prolongation of the QT interval
5. Patient has current evidence of a serious and/or unstable psychiatric, neurologic, cardiovascular, respiratory, gastrointestinal, renal, hepatic, hematologic, or other medical disorder, including cancer or malignancies, which would affect the patient's ability to participate in the study.

Patients will be evaluated at screening to ensure that all criteria for study participation are met. Patients may be excluded from the study based on these assessments (and specifically if it is determined that their baseline health and psychiatric condition do not meet all pre-specified entry criteria).
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

ACADIA Pharmaceuticals Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

171-Alea Research Institute

Phoenix, Arizona, United States

Site Status

156-Woodland International Research Group, LLC

Little Rock, Arkansas, United States

Site Status

111-Woodland Research Northwest, LLC

Rogers, Arkansas, United States

Site Status

167-CITrials - Bellflower

Bellflower, California, United States

Site Status

105-ProScience Research Group

Culver City, California, United States

Site Status

123-Synergy San Diego

Lemon Grove, California, United States

Site Status

164-Artemis Institute for Clinical Research

San Diego, California, United States

Site Status

165-CITrials

Santa Ana, California, United States

Site Status

108-Collaborative Nueroscience Network, LLC

Torrance, California, United States

Site Status

125-Galiz Research

Hialeah, Florida, United States

Site Status

137-Innovative Clinical Research, Inc.

Lauderhill, Florida, United States

Site Status

146-Premier Clinical Research Institute, Inc.

Miami, Florida, United States

Site Status

162-Synexus Clinical Research, Inc.

Atlanta, Georgia, United States

Site Status

168-Atlanta Center for Medical Research

Atlanta, Georgia, United States

Site Status

102-Northwest Behavioral Research Center

Marietta, Georgia, United States

Site Status

114-Northwestern University

Chicago, Illinois, United States

Site Status

101-American Medical Research

Chicago, Illinois, United States

Site Status

130-Alexian Brothers Center for Psychiatric Research

Hoffman Estates, Illinois, United States

Site Status

118-Lake Charles Clinical Trials

Lake Charles, Louisiana, United States

Site Status

124-Altea Research Institute

Las Vegas, Nevada, United States

Site Status

141-Hassman Research Institute

Berlin, New Jersey, United States

Site Status

153-Albuquerque Neuroscience Inc.

Albuquerque, New Mexico, United States

Site Status

104-Neurobehavioral Research, Inc.

Cedarhurst, New York, United States

Site Status

140-Synexus Clinical Research, Inc - 140

Jamaica, New York, United States

Site Status

128-Finger Lakes Clinical Research

Rochester, New York, United States

Site Status

106-New Hope Clinical Research

Charlotte, North Carolina, United States

Site Status

145-Carolina Behavioral Care

Durham, North Carolina, United States

Site Status

110-Cutting Edge Research Group

Oklahoma City, Oklahoma, United States

Site Status

170-Suburban Research Associates

Downingtown, Pennsylvania, United States

Site Status

127-University Hills Clinical Research

Irving, Texas, United States

Site Status

103-Pillar Clinical Research, LLC

Richardson, Texas, United States

Site Status

115-Psychiatric and Behavioral Solutions LLC

Salt Lake City, Utah, United States

Site Status

610-Clinica Privada Banfield S.A.

Buenos Aires, , Argentina

Site Status

625-NOVAIN Neurociencias Group

Buenos Aires, , Argentina

Site Status

603-Fundación para el Estudio y Tratamiento de las Enfermedades Mentales - FETEM

Ciudad Autonoma Buenos Aires, , Argentina

Site Status

601-CENydET- Centro Neurobiologico y de Estres Traumatico-Biopsychomedical Research Group SRL

Ciudad Autonoma de Buenos Aire, , Argentina

Site Status

602-FunDamoS

Ciudad Autonoma de Buenos Aire, , Argentina

Site Status

622-Instituto Medico Damic Srl

Córdoba, , Argentina

Site Status

624-Centro Especializado en Neurociencias CEN

Córdoba, , Argentina

Site Status

626-Sanatorio Prof. Leon S. Morra S.A.

Córdoba, , Argentina

Site Status

617-INSA Instituto de Neurociencias San Agustin S.A.

La Plata, , Argentina

Site Status

623-Clinica Privada de Salud Mental Santa Teresa de Avila

La Plata, , Argentina

Site Status

607-Resolution Psicopharmacology Research Institute

Mendoza, , Argentina

Site Status

454-Mental Health Centre 'Prof. Dr. Ivan Temkov', EOOD

Burgas, , Bulgaria

Site Status

533-State Psychiatric Hospital - Kardzhali, EOOD

Kardzhali, , Bulgaria

Site Status

532-MHAT "Dr. Hristo Stambolski", EOOD

Kazanlak, , Bulgaria

Site Status

569-State Psychiatric Hospital - Lovech

Lovech, , Bulgaria

Site Status

406-State Psychiatric Hospital - Pazardzhik AD

Pazardzhik, , Bulgaria

Site Status

535-UMHAT 'Dr. Georgi Stranski', EAD

Pleven, , Bulgaria

Site Status

586-Medical Center Mentalcare OOD

Plovdiv, , Bulgaria

Site Status

563-MC-Hipokrat-N E00D

Plovdiv, , Bulgaria

Site Status

403-University Multiprofile hospital for activated treatment Sveti Georgi, Clinic of psychiatry

Plovdiv, , Bulgaria

Site Status

592-Medical center Spectar - Plovdiv EOOD

Plovdiv, , Bulgaria

Site Status

570-Medical Centre "Sveti Naum"

Sofia, , Bulgaria

Site Status

497-MHC - Sofia, EOOD

Sofia, , Bulgaria

Site Status

526-DCC "Sv. Vrach and Sv. Sv. Kuzma and Damyan", OOD

Sofia, , Bulgaria

Site Status

402-Military Medical Academy, Multiprofile Hospital for Actie Treatment - Sofia

Sofia, , Bulgaria

Site Status

405-UMHAT "Alexandrovska" EAD

Sofia, , Bulgaria

Site Status

568-Medical Center Hera EOOD

Sofia, , Bulgaria

Site Status

528-Medical Center Intermedica, OOD

Sofia, , Bulgaria

Site Status

404-MHAT-Targovishte, AD

Targovishte, , Bulgaria

Site Status

590-State Psychiatric Hospital - Tzarev Brod

Tsarev Brod, , Bulgaria

Site Status

498-DCC "Mladost M" - Varna, OOD

Varna, , Bulgaria

Site Status

455-Mental Health Center - Veliko Tarnovo EOOD

Veliko Tarnovo, , Bulgaria

Site Status

401-Mental Health Center-Vratsa EOOD

Vratsa, , Bulgaria

Site Status

Chatham-Kent Clinical Trials Research Ctr

Chatham, Ontario, Canada

Site Status

351-McGill University Health Ctr Allan Memorial Int.

Montreal, Quebec, Canada

Site Status

356-Chatham-Kent Clinical Trials Research Ctr

Chatham, , Canada

Site Status

536 - Clinic for psychiatry Vrapce

Zagreb, , Croatia

Site Status

537 - Clinic for psychiatry Vrapce

Zagreb, , Croatia

Site Status

550-Clinic for psychiatry Vrapce

Zagreb, , Croatia

Site Status

557 - Clinic for psychiatry Vrapce

Zagreb, , Croatia

Site Status

594-Klinika za psihijatriju Sveti Ivan, n/p Igor Filipčić or Marija Zelenika

Zagreb, , Croatia

Site Status

512-NeuropsychiatrieHK s.r.o.

Hradec Králové, , Czechia

Site Status

583-Narodni ustav dusevniho zdravi

Klecany, , Czechia

Site Status

519-A-SHINE s.r.o.

Pilsen, , Czechia

Site Status

513-CLINTRIAL s.r.o.

Prague, , Czechia

Site Status

499-MUDr. Tibor Miklos

Prague, , Czechia

Site Status

511-Psychiatrie Ricany s.r.o.

Říčany, , Czechia

Site Status

410-Dr. Máthé és Társa Bt.

Kalocsa, Bács-Kiskun Megye, Hungary

Site Status

411-ÓBudai Egészségűgyi Centrum Kft

Budapest, Pest County, Hungary

Site Status

456-Semmelweis University Department of Psychiatry and Psychotherapy

Budapest, Pest County, Hungary

Site Status

520-Nyiro Gyula Korhaz - Orszagos Pszichiatriai es Addiktologiai Intezet

Budapest, , Hungary

Site Status

440-PsychoTech Kft.

Pécs, , Hungary

Site Status

566-Ospedale San Raffaele (San Raffaele Turro)

Milan, , Italy

Site Status

553-AO Città della Salute e della Scienza di Torino

Torino, , Italy

Site Status

483-Romuvos klinika, UAB

Kaunas, , Lithuania

Site Status

518-Kaunas City Outpatient Clinic, Public Institution

Kaunas, , Lithuania

Site Status

484-Medical Center Puriena JSC

Šilutė, , Lithuania

Site Status

517-Zirmunai Mental Health Center, Public Institution

Vilnius, , Lithuania

Site Status

525-Podlaskie Centrum Psychogeriatrii

Bialystok, , Poland

Site Status

502-Przychodnia Srodmiescie Sp. z o. o.

Bydgoszcz, , Poland

Site Status

579-Centrum Badan Klinicznych P.I. House Sp. z o.o.

Gdansk, , Poland

Site Status

501-Specjalistyczna Praktyka Lekarska Marek Domański

Lublin, , Poland

Site Status

578-MSCZ im. Prof. J. Mazurkiewicza

Pruszków, , Poland

Site Status

505-GUZ Lipetsk Regional psychoneurological Hospital #1

Plekhanovo, Lipetsk Oblast, Russia

Site Status

417-State Budget Healthcare Institution of Stavropol Region (Regional Specialized Psychiatric Hospital #2)

Tonnel’nyy, Stavropol Kray, Russia

Site Status

418-State Budget Healthcare Institution of Arkhangelsk Region "Arkhangelsk Clinical Psychiatric Hospital"

Arkhangelsk, , Russia

Site Status

459-Federal State Budgetary Research Institution "Mental Health Science Center"

Moscow, , Russia

Site Status

573-SBIH of Moscow "Psychiatric Clinical Hospital # 4 n.a. P.B. Gannushkin" Short name: PCH N4 n.a. P.B.Gannushkin

Moscow, , Russia

Site Status

581-SBIH of Moscow "Psych Clinical Hospital #1 N.A. Alekseev"

Moscow, , Russia

Site Status

419-State municipal healthcare Institution "Leningrad region psychoneurological center"

Saint Petersburg, , Russia

Site Status

415-Saint-Petersburg State Healthcare Institution "Saint Nicolas Wonderworker Psychiatric Hospital"

Saint Petersburg, , Russia

Site Status

571-St. Petersburg SHI "Psychoneurological Dispensary #10"

Saint Petersburg, , Russia

Site Status

451-V. M. Bekhterev National Research Medical Center For Psychiatry and Neurology

Saint Petersburg, , Russia

Site Status

453-"Saint-Petersburg Scientific Research Psychoneurological Institute n.a. V.M. Bekhterev"

Saint Petersburg, , Russia

Site Status

465-"Saint-Petersburg Scientific Research Psychoneurological Institute N.A. V.M. Bekhterev"

Saint Petersburg, , Russia

Site Status

495-FSBI "National Medical Scientifi Center of Psychiatry and Neurology n.a. V.M. Bekhterev" MoH

Saint Petersburg, , Russia

Site Status

464-Saint Petersburg State Budget Healthcare Institution "City Psychiatric Hospital No. 6 (Inpatient Department with Treatment Center)"

Saint Petersburg, , Russia

Site Status

443-Saint-Petersburg State Budget Healthcare Institution "Psychoneurological Center #5"

Saint Petersburg, , Russia

Site Status

444-SPHI "City Mental Hospital #3 n.a. I.I Skvortsov-Stepanov"

Saint Petersburg, , Russia

Site Status

452-Saint Petersburg State Public Institution of Healthcare "City Psychiatric Hospital #3 n.a.I.I. Skvortsov-Stepanov

Saint Petersburg, , Russia

Site Status

496-SPHI "City Mental Hospital #3 n.a. I.I Skvortsov-Stepanov

Saint Petersburg, , Russia

Site Status

458-State Budget Healthcare Institution "Samara Psychiatric Hospital"

Saint Petersburg, , Russia

Site Status

416-FSBEI HE "Smolensk State Medical University" of the MoH of the RF

Smolensk, , Russia

Site Status

420-"Podderzhka" Research and Educational Center of Psychotherapy Limited Liability Company

Stavropol, , Russia

Site Status

572-Klinika StoLet" Ltd.

Tomsk, , Russia

Site Status

466-OOO "Lion-Med"

Voronezh, , Russia

Site Status

422-State Budget Healthcare Institution of Yaroslavl Region "Yaroslavl Region Clinical Psychiatric Hospital"

Yaroslavl, , Russia

Site Status

428-Clinical center of Serbia

Belgrade, , Serbia

Site Status

424-Institute of Mental health

Belgrade, , Serbia

Site Status

425-Clinical Hospital Center "Dr. Dragisa Misovic-Dedinje", Clinic of Psychiatry

Belgrade, , Serbia

Site Status

471-Clinic for Psychiatric Diseases "Dr Laza Lazarevic"

Belgrade, , Serbia

Site Status

524-General Hospital Euromedik

Belgrade, , Serbia

Site Status

587-Institute of Mental Health

Belgrade, , Serbia

Site Status

584-Clinic for Psychiatry, Clinical Canter of Serbia

Belgrade, , Serbia

Site Status

472-Special Hospital for Psychiatric Diseases "Kovin"

Kovin, , Serbia

Site Status

493-Special Neuropsychiatric Hospital Kovin

Kovin, , Serbia

Site Status

423-Clinical Center Kragujevac

Kragujevac, , Serbia

Site Status

429-Clinical Center Kragujevac, Clinic of Psychiatry

Kragujevac, , Serbia

Site Status

430-Psychiatric Clinic, Clinical Center Kragujevac

Kragujevac, , Serbia

Site Status

427-Clinical Center Nis, Clinic of Mental Health

Niš, , Serbia

Site Status

585-Special Hospital for Psychiatric Diseases "Gornja Toponica"

Niš, , Serbia

Site Status

593-Specialized Hospital for Neuropsychiatric Diseases "Sveti Vracevi"

Novi Kneževac, , Serbia

Site Status

476-FIDMAG Germanes Hospitalaries

Barcelona, , Spain

Site Status

574-Hospital Clinic de Barcelona

Barcelona, , Spain

Site Status

588-Institucion Hospitalaria Hestia Palau - Ensayos clinicos

Barcelona, , Spain

Site Status

475-Hospital Gregorio Marañon

Madrid, , Spain

Site Status

575-Hospital Universitario 12 de Octubre

Madrid, , Spain

Site Status

494-CSM La Corredoria

Oviedo, , Spain

Site Status

431-Centro de Salud Parquesol, 2ª planta - Servicio de Psiquiatria

Valladolid, , Spain

Site Status

529-Hospital Provincial de Zamora

Zamora, , Spain

Site Status

438-Communal Establishment "Odesa Regional Psychiatric Hospital #2"

Odesa, Oblast, Ukraine

Site Status

462-Communal Establishment "I.I. Mechnykov Dnipropetrovsk Regional Clinical Hospital"

Dnipro, , Ukraine

Site Status

510-CI of Kyiv RC Regional Psychiatric-Narcological Medical Association, Depart #10 (male), Dept #2 (female)

Hlevakha, , Ukraine

Site Status

433-SI "Institute of Neurology, Psychiatry and Narcology of National Academy of Medical Sciences of Ukraine"

Kharkiv, , Ukraine

Site Status

434-State Institution "Institute of Neurology, Psychiatry and Narcology of NAMS of Ukraine", Department of Urgent Psychiatry and Narcology

Kharkiv, , Ukraine

Site Status

582-SI Institute of Neurology,Psychiatry&Narcology of NAMSU

Kharkiv, , Ukraine

Site Status

567-CIH Kharkiv Regional Clinical Psychiatric Hospital #3 Psychiatric Department of Primary Psychotic Episod Short Site name: CIH KRCPH #3 PD of PPE

Kharkiv, , Ukraine

Site Status

461-Kherson Regional Psychiatric Hospital

Kherson, , Ukraine

Site Status

507-Main Military Clinical Hospital of MDU

Kyiv, , Ukraine

Site Status

447-Ukrainian Scientific Research Institute of Social and Forensic Psychiatry and Narcology of Ministry of Healthcare of Ukraine

Kyiv, , Ukraine

Site Status

Kyiv Regional Medical Incorporation Psychiatry Center of Novel Treatment and Rehabilitation of Psychotic Disorders, Department #29, Department #30

Kyiv, , Ukraine

Site Status

460-Kyiv City Psychoneurological Hospital #3, General Psychiatry Department No. 2

Kyiv, , Ukraine

Site Status

435-Kyiv Regional Medical Incorporation "Psychiatry". Center of Novel Treatment and Rehabilitation of Psychotic disorders, build 5, Department #30

Kyiv, , Ukraine

Site Status

564-Regional Clinical Psychiatric Hospital

Nove, , Ukraine

Site Status

509-CI Odesa Regional Medical Centre of Mental Health

Odesa, , Ukraine

Site Status

508-CI Cherkasy Regional Psychiatric Hospital of ChRC Female Dept #11, Male Dept #12

Smila, , Ukraine

Site Status

591-Municipal non-profit enterprise "Transcarpathian Regional Medical Center of Mental Health and Medicine of Addictions" of the Transcarpathian Regional Council, Department of psychiatry

Uzhhorod, , Ukraine

Site Status

Communal Establishment "Acad. O.I. Iushchenko Vinnytsia Regional Psychoneurologic Hospital"

Vinnytsia, , Ukraine

Site Status

432-Municipal Institution "Vinnytsya Regional Psychoneurological Hospital n.a. Acad. O.I. Yushchenko", Male Department No 14, Female Department No 15, Vinnytsya National Medical University n.a. M.I. Pyrogov, Dept of Psychiatry, Narcology and Psychothera

Vinnytsia, , Ukraine

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Bulgaria Canada Croatia Czechia Hungary Italy Lithuania Poland Russia Serbia Spain Ukraine

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2016-003435-38

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

ACP-103-035

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.